Literature DB >> 21242960

Myc/miR-378/TOB2/cyclin D1 functional module regulates oncogenic transformation.

M Feng1, Z Li, M Aau, C H Wong, X Yang, Q Yu.   

Abstract

The c-Myc transcription factor activates a cascade of downstream targets to form a complex transcriptional program that ultimately leads to cellular transformation. Although a large number of protein-encoding genes as well as non-coding RNAs were identified as Myc targets, only a few have been validated to be functionally important for c-Myc-driven transformation. Here, we identify a microRNA (miRNA), miR-378, as a novel target of the c-Myc oncoprotein that is able to cooperate with activated Ras or HER2 to promote cellular transformation. Mechanistically, miR-378 achieves this oncogenic effect, at least in part, by targeting and inhibiting the anti-proliferative BTG family member, TOB2, which is further elucidated as a candidate tumor suppressor to transcriptionally repress proto-oncogene cyclin D1. Therefore, our study identifies miR-378-TOB2-cyclin D1 as a functional module to mediate the cross talk between Myc and Ras signaling in cellular transformation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21242960     DOI: 10.1038/onc.2010.602

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  37 in total

1.  Podocytes regulate the glomerular basement membrane protein nephronectin by means of miR-378a-3p in glomerular diseases.

Authors:  Janina Müller-Deile; Jan Dannenberg; Patricia Schroder; Meei-Hua Lin; Jeffrey H Miner; Rongjun Chen; Jan-Hinrich Bräsen; Thomas Thum; Jenny Nyström; Lynne Beverly Staggs; Hermann Haller; Jan Fiedler; Johan M Lorenzen; Mario Schiffer
Journal:  Kidney Int       Date:  2017-05-03       Impact factor: 10.612

2.  Nondestructive nanostraw intracellular sampling for longitudinal cell monitoring.

Authors:  Yuhong Cao; Martin Hjort; Haodong Chen; Fikri Birey; Sergio A Leal-Ortiz; Crystal M Han; Juan G Santiago; Sergiu P Paşca; Joseph C Wu; Nicholas A Melosh
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-21       Impact factor: 11.205

3.  A novel cardiomyocyte-enriched microRNA, miR-378, targets insulin-like growth factor 1 receptor: implications in postnatal cardiac remodeling and cell survival.

Authors:  Ivana Knezevic; Aalok Patel; Nagalingam R Sundaresan; Mahesh P Gupta; R John Solaro; Raghu S Nagalingam; Madhu Gupta
Journal:  J Biol Chem       Date:  2012-02-24       Impact factor: 5.157

4.  MicroRNA-based screens for synthetic lethal interactions with c-Myc.

Authors:  Youjun Li; Yahui Zhu; Edward V Prochownik
Journal:  RNA Dis       Date:  2016-05-30

5.  Blocking and randomization to improve molecular biomarker discovery.

Authors:  Li-Xuan Qin; Qin Zhou; Faina Bogomolniy; Liliana Villafania; Narciso Olvera; Magali Cavatore; Jaya M Satagopan; Colin B Begg; Douglas A Levine
Journal:  Clin Cancer Res       Date:  2014-05-01       Impact factor: 12.531

6.  microRNA-378a-5p iS a novel positive regulator of melanoma progression.

Authors:  Maria Grazia Tupone; Simona D'Aguanno; Marta Di Martile; Elisabetta Valentini; Marianna Desideri; Daniela Trisciuoglio; Sara Donzelli; Andrea Sacconi; Simonetta Buglioni; Cristiana Ercolani; Alessio Biagioni; Gabriella Fibbi; Luigi Fattore; Rita Mancini; Gennaro Ciliberto; Giovanni Blandino; Donatella Del Bufalo
Journal:  Oncogenesis       Date:  2020-02-14       Impact factor: 7.485

7.  Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis.

Authors:  Klaudia Skrzypek; Magdalena Tertil; Slawomir Golda; Maciej Ciesla; Kazimierz Weglarczyk; Guillaume Collet; Alan Guichard; Magdalena Kozakowska; Jorge Boczkowski; Halina Was; Tomasz Gil; Jaroslaw Kuzdzal; Lucie Muchova; Libor Vitek; Agnieszka Loboda; Alicja Jozkowicz; Claudine Kieda; Jozef Dulak
Journal:  Antioxid Redox Signal       Date:  2013-06-27       Impact factor: 8.401

8.  microRNAs are biomarkers of oncogenic human papillomavirus infections.

Authors:  Xiaohong Wang; Hsu-Kun Wang; Yang Li; Markus Hafner; Nilam Sanjib Banerjee; Shuang Tang; Daniel Briskin; Craig Meyers; Louise T Chow; Xing Xie; Thomas Tuschl; Zhi-Ming Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

9.  EPA significantly improves anti-EGFR targeted therapy by regulating miR-378 expression in colorectal cancer.

Authors:  Wen-Hui Weng; Wai-Hung Leung; Yeu Jye Pang; Li-Wei Kuo; Hsi-Hsien Hsu
Journal:  Oncol Lett       Date:  2018-09-05       Impact factor: 2.967

10.  The intermediate filament vimentin mediates microRNA miR-378 function in cellular self-renewal by regulating the expression of the Sox2 transcription factor.

Authors:  Zhaoqun Deng; William W Du; Ling Fang; Sze Wan Shan; Jun Qian; Jiang Lin; Wei Qian; Jichun Ma; Zina Jeyapalan Rutnam; Burton B Yang
Journal:  J Biol Chem       Date:  2012-11-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.